Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| NPT | Texxon | $8.05 | -$7.70 | -48.89% | 753 | $179M | $3.14$22.38 |
| CING | Cingulate | $8.04 | -$3.62 | -31.05% | 1.2K | $88M | $3.20$11.89 |
| GSIT | Gsi Technology | $5.93 | -$2.56 | -30.17% | 1.8K | $214M | $1.62$18.15 |
| MASK | 3 E Network Technology Group | $2.07 | -$0.83 | -28.62% | 802 | $47M | $2.01$104.81 |
| TKLF | Tokyo Lifestyle | $2.21 | -$0.74 | -25.09% | 47 | $9.4M | $2.10$4.32 |
| CBUS | Cibus | $2.77 | -$0.91 | -24.73% | 1.1M | $183M | $1.09$4.19 |
| RKLX | Tidal Trust II - Defiance Daily Target 2x Long Rklb ETF | $31.99 | -$9.56 | -23.01% | 15.8K | - | $3.32$78.00 |
| SMX | Smx (Security Matters) Public | $8.58 | -$2.25 | -20.78% | 1.1K | $19M | $8.41$30,915.21 |
| CTMX | CytomX Therapeutics | $4.40 | -$1.05 | -19.27% | 193 | $749M | $0.40$8.21 |
| GLGG | Themes ETF Trust - Leverage Shares 2x Long Glxy Daily ETF | $6.19 | -$1.20 | -16.27% | 59 | - | $4.22$45.80 |
| GEMI | Gemini Space Station | $5.96 | -$1.15 | -16.17% | 5K | $701M | $5.57$45.89 |
| FLX | BingEx | $2.40 | -$0.45 | -15.79% | 152.6K | $128M | $2.01$8.48 |
| SDST | Stardust Power | $2.39 | -$0.44 | -15.55% | 4 | $24M | $1.43$8.43 |
| FBYD | Falcon's Beyond Global | $6.68 | -$1.20 | -15.23% | 116.5K | $323M | $3.71$29.02 |
Related Articles
Featured Article
Is This Innovative Cancer Research Biotech a Buy?
Zhiyuan Sun|May 20, 2020
Unlike many other cancer-research companies, CytomX is choosing an unconventional approach: turning tumors' high levels of protein activities against themselves. Will it be successful?
These Gene-Editing Pioneers Are Making Bold Bets in Agriculture
Maxx Chatsko|Jan 18, 2020
Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.
